Olaratumab: a platelet-derived growth factor receptor-α-blocking antibody for the treatment of soft tissue sarcoma

Pender A, Jones RL

Clinical Pharmacology: Advances and Applications 2017, 9:159-164

Published Date: 4 December 2017